BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lee T, Teng TZJ, Shelat VG. Carbohydrate antigen 19-9 — tumor marker: Past, present, and future. World J Gastrointest Surg 2020; 12(12): 468-490 [PMID: 33437400 DOI: 10.4240/wjgs.v12.i12.468]
URL: https://www.wjgnet.com/1948-5182/full/v12/i12/468.htm
Number Citing Articles
1
Yizhen Zhang, Qingwei Jiang, Qiang Wang, Yunlu Feng, Dongsheng Wu, Tao Guo, Shengyu Zhang, Xi Chen, Yingyun Yang, Wen Shi, Xi Wu, Aiming Yang. Predicting Malignancy of Biliary Stricture with a Nomogram in Patients with a Non-Malignant Endoscopic Tissue Diagnosis: A Retrospective StudyCancer Management and Research 2021; : 7735 doi: 10.2147/CMAR.S333333
2
Niloofar Asadi Hanjani, Nazanin Esmaelizad, Saba Zanganeh, Abdulwahab Teflischi Gharavi, Pegah Heidarizadeh, Maryam Radfar, Fateme Omidi, Ronan MacLoughlin, Mohammad Doroudian. Emerging role of exosomes as biomarkers in cancer treatment and diagnosisCritical Reviews in Oncology/Hematology 2022; 169: 103565 doi: 10.1016/j.critrevonc.2021.103565
3
Tsinrong Lee, Thomas Zheng Jie Teng, Vishal G Shelat. Choledochoscopy: An updateWorld Journal of Gastrointestinal Endoscopy 2021; 13(12): 571-592 doi: 10.4253/wjge.v13.i12.571
4
Jacek Baj, Łukasz Bryliński, Filip Woliński, Michał Granat, Katarzyna Kostelecka, Piotr Duda, Jolanta Flieger, Grzegorz Teresiński, Grzegorz Buszewicz, Marzena Furtak-Niczyporuk, Piero Portincasa. Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already KnowCancers 2022; 14(6): 1493 doi: 10.3390/cancers14061493
5
Shigemasa Takamizawa, Tatsunori Shimoi, Masayuki Yoshida, Momoko Tokura, Shu Yazaki, Chiharu Mizoguchi, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Yuki Kojima, Hitomi Sumiyoshi-Okuma, Tadaaki Nishikawa, Emi Noguchi, Kazuki Sudo, Kan Yonemori. Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective studyBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09514-3
6
Yuichiro Onuki, Hirochika Matsubara, Ryunosuke Koizumi, Mamoru Muto, Harunobu Sasanuma, Daisuke Sato, Aya Sugimura, Tsuyoshi Uchida, Hiroyasu Matsuoka, Hiroyuki Nakajima. Prognostic evaluation of preoperative serum tumor marker‐negative cases in non‐small cell lung cancer: A retrospective studyCancer Reports 2022;  doi: 10.1002/cnr2.1696
7
Beatriz A. Gonzales, Alessandro L. Diniz, Silvio M. Torres, Héber Salvador de Castro Ribeiro, Igor Correia de Farias, André Luís de Godoy, Felipe J. F. Coimbra, Victor H. Fonseca de Jesus. Patterns of disease relapse and posttreatment follow‐up of patients with resected pancreatic adenocarcinoma: A single‐center analysisJournal of Surgical Oncology 2022; 126(4): 708 doi: 10.1002/jso.26985
8
Sima Kalantari, Akram Pourshams, Raheleh Roudi, Hakimeh Zali, Mojgan Bandehpour, Abolfazl Kalantari, Reza Ghanbari, Alberto D'Angelo, Bahram Kazemi, Zahra Madjd. Identification of potential common molecular factors of pancreatic cancer and diabetes mellitus using microarray data analysis combined with bioinformatics techniques and experimental validationBiomedical and Biotechnology Research Journal (BBRJ) 2021; 5(3): 294 doi: 10.4103/bbrj.bbrj_122_21
9
Erkan Topkan, Ugur Selek, Berrin Pehlivan, Ahmet Kucuk, Veysel Haksoyler, Nulifer Kilic Durankus, Duygu Sezen, Yasemin Bolukbasi. The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent ChemoradiotherapyJournal of Inflammation Research 2021; : 4433 doi: 10.2147/JIR.S329611
10
Peng Ge, Yalan Luo, Haiyang Chen, Jiayue Liu, Haoya Guo, Caiming Xu, Jialin Qu, Guixin Zhang, Hailong Chen. Application of Mass Spectrometry in Pancreatic Cancer Translational ResearchFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.667427
11
Nebojsa Manojlovic, Goran Savic, Bojan Nikolic, Nemanja Rancic. Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapyWorld Journal of Clinical Cases 2022; 10(3): 899-918 doi: 10.12998/wjcc.v10.i3.899
12
Daniel Vasile Balaban, Flavius Stefan Marin, George Manucu, Andreea Zoican, Marina Ciochina, Victor Mina, Cristina Patoni, Catalina Vladut, Sandica Bucurica, Raluca Simona Costache, Florentina Ionita-Radu, Mariana Jinga. Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancerWorld Journal of Clinical Oncology 2022; 13(7): 630-640 doi: 10.5306/wjco.v13.i7.630
13
Fahmy T. Ali, Reham M. Soliman, Nahla S. Hassan, Ahmed M. Ibrahim, Mayada M. El-Gizawy, Abd Allah Y. Mandoh, Ehab A. Ibrahim, Elizabeth Christie. Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancerPLOS ONE 2022; 17(8): e0272308 doi: 10.1371/journal.pone.0272308
14
Biaoming Xu, Yu Chen, Mingjing Peng, Jin Hai Zheng, Chaohui Zuo. Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinomaInternational Journal of Cancer 2022;  doi: 10.1002/ijc.34195
15
Sonia Perales, Carolina Torres, Cristina Jimenez-Luna, Jose Prados, Joaquina Martinez-Galan, Jose Manuel Sanchez-Manas, Octavio Caba. Liquid biopsy approach to pancreatic cancerWorld Journal of Gastrointestinal Oncology 2021; 13(10): 1263-1287 doi: 10.4251/wjgo.v13.i10.1263
16
Christina Jane Vellan, Jaime Jacqueline Jayapalan, Boon-Koon Yoong, Azlina Abdul-Aziz, Sarni Mat-Junit, Perumal Subramanian. Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A ReviewInternational Journal of Molecular Sciences 2022; 23(4): 2093 doi: 10.3390/ijms23042093
17
Brian M. Fung, James H. Tabibian. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practicesExpert Review of Gastroenterology & Hepatology 2021; 15(5): 487 doi: 10.1080/17474124.2021.1900732
18
Jia Jia Wee, Charles K F Vu, Cristine Szu Lyn Ding, Vishal G Shelat. Intrapancreatic accessory spleen with an epidermoid cyst: a malignant mimicryBMJ Case Reports 2022; 15(2): e247737 doi: 10.1136/bcr-2021-247737
19
Kai Siang Chan, Vishal Shelat. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases2022; : 509 doi: 10.1007/978-981-19-0063-1_66
20
Valeria Tonini, Manuel Zanni. Early diagnosis of pancreatic cancer: What strategies to avoid a foretold catastropheWorld Journal of Gastroenterology 2022; 28(31): 4235-4248 doi: 10.3748/wjg.v28.i31.4235
21
Taisuke Imamura, Katsuhisa Ohgi, Yukiyasu Okamura, Teiichi Sugiura, Takaaki Ito, Yusuke Yamamoto, Ryo Ashida, Shimpei Otsuka, Shunsuke Tamura, Katsuhiko Uesaka. The clinical benefits of performing staging laparoscopy for pancreatic cancer treatmentPancreatology 2022; 22(5): 636 doi: 10.1016/j.pan.2022.03.017
22
Xiaolei Zhou. Meta-analysis of the diagnostic performance of serum carbohydrate antigen 19-9 for the detection of gallbladder cancerThe International Journal of Biological Markers 2022; 37(1): 81 doi: 10.1177/17246008211068866
23
Filbert H. Juwono, W.K. Wong, Hui Ting Pek, Saaveethya Sivakumar, Donata D. Acula. Ovarian cancer detection using optimized machine learning models with adaptive differential evolutionBiomedical Signal Processing and Control 2022; 77: 103785 doi: 10.1016/j.bspc.2022.103785
24
Kendelle J. Murphy, Cecilia R. Chambers, David Herrmann, Paul Timpson, Brooke A. Pereira. Dynamic Stromal Alterations Influence Tumor-Stroma Crosstalk to Promote Pancreatic Cancer and Treatment ResistanceCancers 2021; 13(14): 3481 doi: 10.3390/cancers13143481
25
Francesca Pezzuto, Francesco Izzo, Pasquale De Luca, Elio Biffali, Luigi Buonaguro, Fabiana Tatangelo, Franco Maria Buonaguro, Maria Lina Tornesello. Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular CarcinomaCancers 2021; 13(15): 3771 doi: 10.3390/cancers13153771
26
Yuki Shimizu, Shintaro Kanda, Toshirou Fukushima, Takashi Kobayashi, Ryoichi Kondo, Tomonobu Koizumi. Increased carbohydrate antigen 19‐9 expression in a thymic neuroendocrine tumorThoracic Cancer 2021; 12(21): 2949 doi: 10.1111/1759-7714.14153
27
Bernard Jonathan Christian Yong, Made Wirama Diyana. Low Carbohydrate Antigen 19-9 (CA 19-9) Levels in a Patient Highly Suspected of Having Caput Pancreas TumorCureus 2022;  doi: 10.7759/cureus.24357
28
Phyllis A. Gimotty, Jacob E. Till, Shirsa Udgata, Naomi Takenaka, Stephanie S. Yee, Michael J. LaRiviere, Mark H. O’Hara, Kim A. Reiss, Peter O'Dwyer, Bryson W. Katona, Daniel Herman, Erica L. Carpenter, Kenneth S. Zaret. THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinomaOncotarget 2021; 12(22): 2266 doi: 10.18632/oncotarget.28099
29
Sowbharnika Arivazhagan, Deepti Kantamani, Natalee E Tanner, Madappa N Kundranda, M. Patrick Stagg. Infection Masquerading as Recurrence of Pancreatic Ductal Adenocarcinoma: A Cautionary TaleCureus 2021;  doi: 10.7759/cureus.17010
30
Anil Aysal, Ozgul Sagol. Biomarkers in Carcinoma of Unknown Primary2022; : 201 doi: 10.1007/978-3-030-84432-5_8
31
Thomas Zheng Jie Teng, Branden Qi Yu Chua, Vishal G Shelat. Carcinosarcoma of gallbladder: A world reviewWorld Journal of Clinical Oncology 2021; 12(12): 1244-1263 doi: 10.5306/wjco.v12.i12.1244
32
Hui Li, Rongqiang Liu, Haizhou Qiu, Yang Huang, Wenbin Liu, Jiaxin Li, Hong Wu, Genshu Wang, Dewei Li. Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional StudyFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.829407
33
Ji Ha Lim, Jung Wook Huh, Woo Yong Lee, Seong Hyeon Yun, Hee Cheol Kim, Yong Beom Cho, Yoon Ah Park, Jung Kyong Shin. Comparison of Long-Term Survival Outcomes of T4a and T4b Colorectal CancerFrontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.780684
34
Makoto Takeda, Yoshinori Onuki, Kosuke Oishi, Osamu Kubota, Takashi Uchiyama, Yoshifumi Arai, Hiroya Takeuchi. Giant Mucinous Carcinoma Originating from the Appendix: A Case ReportInternational Surgery 2021; 105(1-3): 697 doi: 10.9738/INTSURG-D-20-00044.1
35
Barbara Link, Adriana Torres Crigna, Michael Hölzel, Frank A. Giordano, Olga Golubnitschaja. Abscopal Effects in Metastatic Cancer: Is a Predictive Approach Possible to Improve Individual Outcomes?Journal of Clinical Medicine 2021; 10(21): 5124 doi: 10.3390/jcm10215124
36
Patrick Michl, Matthias Löhr, John P. Neoptolemos, Gabriele Capurso, Vinciane Rebours, Nuria Malats, Mathilde Ollivier, Luigi Ricciardiello. UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and betterUnited European Gastroenterology Journal 2021; 9(7): 860 doi: 10.1002/ueg2.12123
37
Ruth González-Gómez, Roberto A. Pazo-Cid, Luis Sarría, Miguel Ángel Morcillo, Alberto J. Schuhmacher. Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission TomographyJournal of Clinical Medicine 2021; 10(6): 1151 doi: 10.3390/jcm10061151